Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows From Operating Activities:
Net loss	$ (3,806,608)	$ (7,744,610)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	229,258	172,680
Inventory write down	104,449	0
Amortization of debt discount	439,051	3,069,488
Addition of PIK monitoring fee to note payable	120,716	0
Change in fair value of foreign exchange contract derivative liability.	(186,982)	1,626,030
Change in fair value of warrant liability	(1,597,000)	0
Changes in operating assets and liabilities:
Prepaid expenses and other receivables, VAT receivable and deposit on foreign exchange deposit	904,379	(1,183,997)
Inventory	(1,260,987)	(422,197)
Accounts payable	92,154	164,794
Receivable/payable to related parties	(824,986)	223,678
Accrued expense and other liabilities	62,447	(160,662)
Deferred revenue	0	(294,288)
Net cash used in operating activities	(5,724,109)	(4,549,084)
Cash Flows From Investing Activities:
Capitalized patent costs	0	(144,343)
Capitalized software development costs	0	(27,879)
Purchase of property and equipment	(66,379)	(208,945)
Net cash used in investing activities	(66,379)	(381,167)
Cash Flows From Financing Activities:
Proceeds from issuance of note payable	6,500,000	4,700,000
Principal payments on notes payable	(6,178,261)	(6,274,282)
Net cash provided by (used) in financing activities	321,739	(1,574,282)
Net decrease in cash and restricted cash	(5,468,749)	(6,504,533)
Effect of exchange rate changes on cash and restricted cash	(258,167)	(1,135,050)
Cash, cash equivalent and restricted cash at beginning of period	10,105,135	17,749,233
Cash, cash equivalent and restricted cash at end of period	4,378,219	10,109,650
Cash paid for:
Interest	921,000	1,299,000
Supplemental schedule of non-cash transactions:
Debt discount recognized upon issuance of notes payable	$ 1,310,000	$ 0